Aims: To examine methods for the identification of previously undetected dysglycaemia [diabetes and impaired glucose tolerance (IGT)] in patients investigated for possible acute coronary syndrome. Specifically, we wished to examine whether the recently advocated use of glycosylated haemoglobin (HbA1c) would enhance detection rates for diabetes in these patients. Methods: Patients (n = 200) investigated for possible acute coronary syndrome and not previously known to have diabetes were recruited and anthropometric data collected. Random plasma glucose concentrations followed by oral glucose tolerance tests, HbA1c, fasting lipids, high sensitivity C-reactive protein and homeostatic modular assessment-insulin resistance were obtained during admission. Following discharge, the fasting plasma glucose (FPG) was repeated to determine the importance of sequential fasting levels. The accuracy of individual tests, combinations and sequential testing was assessed using receiver operating characteristic curves. A predictive index (PI) was generated using stepwise logistic regression models. Results: The prevalence of diabetes and IGT were 21 and 32%, respectively. FPG >6.0 mmol/l and HbA1c !6.0% had specificities of 94.9% and 93.6% but sensitivities of only 31.7 and 39.0%, respectively. Combination and sequential testing provided little additional benefit. Use of a PI comprising FPG, HbA1c and age provided the best overall performance (75.6% sensitivity, 77.1% specificity, negative predictive value 92.4%). Conclusions: Our data confirm the high prevalence of dysglycaemia in this cohort. The commonly advocated screening tools have significant limitations if used in isolation, combination or sequentially. Our approach using a PI offers improved performance partly as it uses continuous data rather than arbitrary cut-off values.
Introduction
Diabetes mellitus (DM) is a major public health concern with an expected prevalence of 2.5 million patients by 2010 in UK and predicted to be 300 million by 2025 worldwide. It has a major impact on health resources particularly as a result of vascular disease. Despite this, almost half of patients with DM remain undiagnosed. 1 The National Service Framework (NSF) for diabetes in UK recommends 'opportunistic' screening for diabetes. 2 Screening for diabetes in high-risk groups may offer a way forward to identifying these unrecognized patients with DM.
Emerging evidence suggest a high prevalence of unrecognized impaired glucose tolerance (IGT) and/ or DM in patients admitted to hospital with acute myocardial infarction (AMI) and acute coronary syndrome. 3 Furthermore, such dysglycaemia has been shown to be associated with an increase in cardiovascular mortality. Identifying these patients, therefore, provides an opportunity to reduce subsequent cardiovascular events.
Although the oral glucose tolerance test (OGTT) represents the 'gold standard' for the identification of dysglycaemia, it is impractical as a screening test, particularly in an acute setting, due to high cost, poor acceptability to patients and a time-consuming protocol. While current guidance suggests screening with fasting glucose measurements, there are suggestions that this alone may miss a significant proportion of patients with latent DM. Okosieme et al. 4 highlight the paucity of evidence in this area, but emphasize the importance of implementing effective screening protocols.
In a cohort of patients not known to have diabetes presenting to an acute unit with acute coronary syndrome, this study aims to (i) examine the effectiveness of single screening tests as advised in current guidance, (ii) assess the effectiveness of combinations of tests advocated by other studies and (iii) explore a predictive index (PI) as a potential approach for identifying patients with DM. Our study also provides an assessment of the prevalence of dysglycaemia in this population.
Methods Patients
Consecutive patients, not previously known to have diabetes (n = 200), presenting with cardiac-sounding chest pain and investigated for acute coronary syndrome were recruited from the Prince Charles Hospital, Merthyr Tydfil between June 2004 and September 2005. As ischaemic heart disease is a well-recognized risk factor for glycaemic abnormalities, we wished to explore whether those patients with signs and/or symptoms of acute coronary syndrome would also constitute a high-risk group.
The study was approved by the South Wales Local Research Ethical Committee and written consent was obtained from all patients.
Data collection
Data collected during the admission included patient demographic (age, gender) and anthropometric measures [body mass index (BMI), waist circumference (WC)] and laboratory parameters comprising lipid profile [total cholesterol, high-density lipoprotein cholesterol (HDL) and low-density lipoprotein cholesterol (LDL) cholesterol, triglycerides], random plasma glucose (RPG), fasting plasma glucose (FPG), glycosylated haemoglobin (HbA1c), serum troponin I and homeostatic modular assessment-insulin resistance (HOMA-IR). Six weeks following discharge, the FPG measurement was repeated. All glucose results shown refer to venous plasma glucose concentrations. No glycaemia-related intervention was implemented between admission and 6 weeks post discharge. Patients with AMI had the usual post-event care.
OGTT
A standard OGTT, using 75 g of glucose, was performed within 72 h of admission in all patients with a FPG <7 mmol/l (n = 192). OGTT, RPG and FPG results were interpreted in accordance with the 1998 World Health Organization (WHO) and American Diabetes Association criteria. 5, 6 Six patients did not progress to OGTT as their FPG was !7.0 mmol/l and the 2-h OGTT value was not obtained on two patients (FPG 4.8 and 6.6 mmol/l).
Subject classification
Based on the OGTT 2-h plasma glucose concentration (see Okosieme et al. 4 ), patients were classified into three groups-normal glucose tolerance (NGT), IGT and DM-according to the WHO 1998 criteria (<7.8, 7.8-11.0 and !11.1 mmol/l, respectively). Each of the six patients with FPG !7.0 mmol/l were classified as DM and did not undergo OGTT.
Statistical methods
All statistical analyses were performed using Stata version 8 (Stata Corporation, College Station, TX). Comparisons between NGT (as reference group) and IGT and DM groups individually (defined from 2-h OGTT results as described above) were performed using multinomial logistic regression models. Logistic regression models were used to assess predictors of DM compared with NGT and IGT combined. Area under the curve (AUC) data for the 2-h OGTT results were obtained from receiver operating characteristic (ROC) curves, a commonly used tool for evaluating the predictive power of logistic regression models. The PI was generated using stepwise logistic regression.
Results
Demographics Table 1 shows the demographics of the study populations. As expected, presence of an elevated troponin I was more common in both DM and IGT groups. BMI, WC and age increased across the three groups whereas, of the lipid parameters, only HDL cholesterol (and hence total:HDL cholesterol ratio) was significantly different between NGT and the other two groups. Table 2 shows the ability of a range of parameters, based on WHO and ADA cut-offs, in predicting presence of DM. Except for the sequential testing (see below), all analyses were based on admission results. None of the single tests performed well, though an HbA1c of !6.0 achieved the greatest overall accuracy. Of the commonly used variables (RPG, FPG and HbA1c), a FPG of >5.5 achieved the largest AUC and largest negative predictive value (NPV). Therefore, of the single tests studied, a value of 5.5 would represent the best rule out tool.
Effectiveness of single tests

Combining common tests
We then examined combinations of these common tests both as additive (e.g. FPG >5.5 and HbA1c !6.0) and, as suggested previously, 4 as cumulative [e.g. FPG >5.5 or HbA1c !6.0]. However, while overall the additive combinations improved specificity and positive predictive value (PPV), sensitivities remained poor. For the cumulative combinations, sensitivities were improved at the expense of specificity when compared with single tests. In the case of FPG >5.5 or RPG !7.8, sensitivity was poorer, but specificity improved compared with that described by Okosieme et al. 4 We then investigated the effect of using the algorithm proposed by Manley et al. 7 who advocated an alternative approach to combining FPG and HbA1c (Figure 1a) . They proposed utilizing a stepwise approach initially using FPG (those with FPG !7.0 mmol/l had DM and did not require OGTT) followed by HbA1c in those with a FPG <7.0 mmol/l. They suggested that OGTT was only 
Sequential testing
The effectiveness of repeat FPG testing was then examined using the results of the admission and 6-week tests (sequential variables). As expected, this showed improved performance for the diagnosis of DM, using both 6.0 and 5.5 as cut-off. Of these two, the 6.0 cut-off had the best PPV and overall accuracy, though only 12 patients had this combination, thereby limiting the reliability of these data.
Use of the PI to identify DM patients
Given the generally poor performance using the above approaches, we therefore sought to use a PI approach. We initially performed univariate analysis with dichotomization of some variables to obtain the optimum odds ratios (ORs). For example, age was dichotomized to !65 years, BMI to !25 and WC to !110 cm as these gave improved significance over continuous variables and provided improved ORs over other clinically-meaningful cut-offs. We then used a stepwise logistic regression model. This showed that only FPG (P < 0.001, coefficient 1.23), HbA1c (P = 0.002, coefficient 1.59) and age !65 years (P = 0.049, coefficient 0.87) were significant variables. We then simplified the model by multiplying coefficients by three and rounding to the nearest integers to generate the PI below:
This generated scores between 40.1 and 82.8 for individual patients. Results for dichotomization of this score based on a cut-off of 50 are shown in Table 2 . This approach generated much improved performance in terms of AUC, NPV and sensitivity.
Substituting the HbA1c !6% advocated by Manley et al. 7 with this PI in their algorithm identified 60/192 patients with PI score >50 of whom 25 (41.7%) were DM on OGTT (Figure 1b) . Of the remaining 132, only 10 (7.6%) of patients defined by this algorithm as NGT actually had DM on OGTT.
Conclusions
Our study confirms that previously unrecognized dysglycaemia is common in patients presenting with acute coronary syndrome. Of our cohort of patients who were previously not known to have DM, one-fifth of patients were subsequently found to have DM, as diagnosed by a 2-h OGTT glucose value of !11.1 mmol/l, whereas a further one-third demonstrated IGT. This is similar to previous studies 4 and illustrates the importance of screening in this high-risk group. Norhammar et al. 3 showed that, in a population of patients with AMI, the prevalence of IGT was similar (35%) and that of DM was slightly higher (31%) than our cohort. Similarly, Bartnik 8 identified prevalence of 36 and 22% for IGT and DM, respectively, in a large population of acute coronary artery disease but no previous history of dysglycaemia.
Our data indicate that individual screening tests will miss a significant proportion of patients with DM. Indeed, at accepted WHO and ADA cut-offs, PPVs were poor, suggesting a significant proportion of DM patients would have been missed. This is in keeping with Okosieme et al., 4 though their study identified improved sensitivities for FPG >5.5 mmol/l and for RPG !7.8 mmol/l.
Additive combinations of tests provided improved specificities and PPV, though sensitivities remained poor. In our cohort, the combination of HbA1c !6.0% and FPG >5.5 mmol/l proved to be the most promising, supporting the increasing role of glycosylated haemoglobin in diagnosis. 7, 9 Cumulative combinations provided marginally improved sensitivities over single tests, though the combination of FPG >5.5 mmol/l or RPG !7.8 mmol/l suggested by Okosieme et al. 4 proved to be one of the least effective of these.
Sequential fasting glucose testing provided improved AUC and overall accuracy over a single test, but few patients demonstrated two values >6.0 mmol/l and PPV remained poor when two FPG values >5.5 mmol/l were used, again suggesting that half of the DM patients would have been missed.
We therefore sought to examine the potential of a PI approach to improve performance. This approach essentially weights significant predictors according to their statistical importance and generates a score for each individual. A similar approach has been used previously (interestingly incorporating similar variables to our PI: logHbA1c, FPG, age and HDL cholesterol) using an ordinal logistic regression approach . 10 The generated PI demonstrated significantly improved AUC and sensitivity. Although the PPV remained limited, the NPV of 92.4% indicates that this approach could prove valuable as a rule-out tool for high-risk patients.
In patients with a FPG <7.0 mmol/l, the algorithm proposed by Manley et al. 7 had a better NPV (93.1% in their UK validation set, using HbA1c !6.0% alone) than our equivalent for HbA1c !6.0% alone (85.5%), but similar to our PI in this group (91.8%). The PPV value for Manley et al. 7 was, however, relatively low (22.4%) compared with our PI (41.7%). We would therefore advocate a modification to the algorithm suggested by Manley et al. 7 by replacing the HbA1c !6.0% step with thePI.
In summary, our data confirm the high prevalence of dysglycaemia in this cohort, supporting the view that screening for diabetes is important. However, our data also show that the commonly advocated screening tools have significant limitations if used in isolation, combination or sequentially. We therefore advocate continuing to use the FPG cut-off as a first line screen with those patients with values !7.0 mmol/l being defined as diabetes. In those with FPG <7.0 mmol/l we would suggest the use of a PI approach to identify those requiring OGTT. This modified Manley et al. 7 algorithm offers improved performance, partly as it uses continuous data rather than arbitrary cut-off values though, as with the Manley algorithm, it would require validation in an independent cohort.
